Newsfeeds - Spark Newswire

3 minute read

Mid-Afternoon Market Update: Dow Rises Around 150 Points; Semler Scientific Shares Slide

Today, 12:15 PM

Toward the end of trading Tuesday, the Dow traded up 0.42% to 36,063.98 while the NASDAQ rose 0.03% to 15,600.42. The S&P also rose, gaining 0.28% to 4,626.45.

CAR

2 minute read

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 12:15 PM

ALDX

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 12:15 PM

Gainers

ENZ

3 minute read

46 Biggest Movers From Yesterday

By Lisa Levin

Today, 12:15 PM

Gainers

ACY

3 minute read

36 Biggest Movers From Yesterday

By Lisa Levin

Today, 12:15 PM

Gainers Bit Digital, Inc. (NASDAQ: BTBT) shares climbed 36.4% to settle at $10.35 on Tuesday amid an increase in the price of Bitcoin and Ethereum.

ACMR

4 minute read

48 Biggest Movers From Friday

By Lisa Levin

Today, 12:15 PM

Gainers Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by AstraZeneca for patients with unresectable, stage 3 non-small cell lung cancer.

AKYA

1 minute read

Icosavax Q2 EPS $(2.86) Down From $(2.45) YoY

By Benzinga Newsdesk

Today, 12:15 PM

Icosavax (NASDAQ:ICVX) reported quarterly losses of $(2.86) per share. This is a 16.73 percent decrease over losses of $(2.45) per share from the same period last year.

ICVX

3 minute read

FDA
News

Icosavax Initiates Phase 1/1b Trial of VLP Vaccine Candidate Against Respiratory Syncytial Virus

By Benzinga Newsdesk

Today, 12:15 PM

Icosavax, Inc. (NASDAQ:ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, today announced the initiation of a

ICVX

5 minute read

60 Biggest Movers From Yesterday

By Lisa Levin

Today, 12:15 PM

Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.

ABVC

4 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For August 23, 2021

By Benzinga Insights

Today, 12:15 PM

Upgrades JP Morgan upgraded the previous rating for Pearson PLC (NYSE:PSO) from Neutral to Overweight. The current stock performance of Pearson shows a 52-week-high of $12.38 and a 52-week-low of $6.13. Moreover, at the end of the last trading period, the closing price was at $10.41.

ACVA